0001901003-21-000001.txt : 20211222 0001901003-21-000001.hdr.sgml : 20211222 20211222162027 ACCESSION NUMBER: 0001901003-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 EFFECTIVENESS DATE: 20211222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Deep Apple Therapeutics, Inc. CENTRAL INDEX KEY: 0001901003 IRS NUMBER: 873668675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-426368 FILM NUMBER: 211513499 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 857-352-3657 MAIL ADDRESS: STREET 1: 230 PARK AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10169 D 1 primary_doc.xml X0708 D LIVE 0001901003 Deep Apple Therapeutics, Inc. 230 PARK AVENUE, SUITE 2800 NEW YORK NY NEW YORK 10169 857-352-3657 DELAWARE None None Corporation true 2021 Spiros Liras c/o Deep Apple Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Executive Officer Director Seth Harrison c/o Deep Apple Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Paul Da Silva Jardine c/o Deep Apple Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Michael Ehlers c/o Deep Apple Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Brian Shoichet c/o Deep Apple Therapeutics, Inc. 230 Park Avenue, Suite 2800 New York NY NEW YORK 10169 Director Biotechnology Decline to Disclose 06b false 2021-12-06 false true false 0 52000000 5000000 47000000 false 1 0 0 0 false Deep Apple Therapeutics, Inc. /s/ Spiros Liras Spiros Liras President 2021-12-22